Impact of the Magnitude and Timing of Fluid Overload on Outcomes in Critically Ill Children: A Report From the Multicenter International Assessment of Worldwide Acute Kidney Injury, Renal Angina, and Epidemiology (AWARE) Study

With the recognition that fluid overload (FO) has a detrimental impact on critically ill children, the critical care nephrology community has focused on identifying clinically meaningful targets for intervention. The current study aims to evaluate the epidemiology and outcomes associated with FO in...

Full description

Saved in:
Bibliographic Details
Published in:Critical care medicine Vol. 51; no. 5; p. 606
Main Authors: Selewski, David T, Gist, Katja M, Basu, Rajit K, Goldstein, Stuart L, Zappitelli, Michael, Soranno, Danielle E, Mammen, Cherry, Sutherland, Scott M, Askenazi, David J, Ricci, Zaccaria, Akcan-Arikan, Ayse, Gorga, Stephen M, Gillespie, Scott E, Woroniecki, Robert
Format: Journal Article
Language:English
Published: United States 01.05.2023
Subjects:
ISSN:1530-0293, 1530-0293
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract With the recognition that fluid overload (FO) has a detrimental impact on critically ill children, the critical care nephrology community has focused on identifying clinically meaningful targets for intervention. The current study aims to evaluate the epidemiology and outcomes associated with FO in an international multicenter cohort of critically ill children. The current study also aims to evaluate the association of FO at predetermined clinically relevant thresholds and time points (FO ≥ 5% and FO ≥ 10% at the end of ICU days 1 and 2) with outcomes. Prospective cohort study. Multicenter, international collaborative of 32 pediatric ICUs. A total of 5,079 children and young adults admitted consecutively to pediatric ICUs as part of the Assessment of the Worldwide Acute Kidney Injury, Renal Angina and Epidemiology Study. None. The FO thresholds at the time points of interest occurred commonly in the cohort (FO ≥ 5%Day1 in 38.1% [ n = 1753], FO ≥ 10%Day1 in 11.7% [ n = 537], FO ≥ 5%Day2 in 53.3% [ n = 1,539], FO ≥ 10%Day2 in 25.1% [ n = 724]). On Day1, multivariable modeling demonstrated that FO ≥ 5% was associated with fewer ICU-free days, and FO ≥ 10% was associated with higher mortality and fewer ICU and ventilator-free days. On multivariable modeling, FO-peak, Day2 FO ≥ 5%, and Day2 FO ≥ 10% were associated with higher mortality and fewer ICU and ventilator-free days. This study found that mild-to-moderate FO as early as at the end of ICU Day1 is associated with adverse outcomes. The current study fills an important void in the literature by identifying critical combinations of FO timing and quantity associated with adverse outcomes (FO ≥ 5%Day1, FO ≥10%Day1, FO ≥ 5%Day2, and FO ≥ 10%Day2). Those novel findings will help guide the development of interventional strategies and trials targeting the treatment and prevention of clinically relevant FO.
AbstractList With the recognition that fluid overload (FO) has a detrimental impact on critically ill children, the critical care nephrology community has focused on identifying clinically meaningful targets for intervention. The current study aims to evaluate the epidemiology and outcomes associated with FO in an international multicenter cohort of critically ill children. The current study also aims to evaluate the association of FO at predetermined clinically relevant thresholds and time points (FO ≥ 5% and FO ≥ 10% at the end of ICU days 1 and 2) with outcomes. Prospective cohort study. Multicenter, international collaborative of 32 pediatric ICUs. A total of 5,079 children and young adults admitted consecutively to pediatric ICUs as part of the Assessment of the Worldwide Acute Kidney Injury, Renal Angina and Epidemiology Study. None. The FO thresholds at the time points of interest occurred commonly in the cohort (FO ≥ 5%Day1 in 38.1% [ n = 1753], FO ≥ 10%Day1 in 11.7% [ n = 537], FO ≥ 5%Day2 in 53.3% [ n = 1,539], FO ≥ 10%Day2 in 25.1% [ n = 724]). On Day1, multivariable modeling demonstrated that FO ≥ 5% was associated with fewer ICU-free days, and FO ≥ 10% was associated with higher mortality and fewer ICU and ventilator-free days. On multivariable modeling, FO-peak, Day2 FO ≥ 5%, and Day2 FO ≥ 10% were associated with higher mortality and fewer ICU and ventilator-free days. This study found that mild-to-moderate FO as early as at the end of ICU Day1 is associated with adverse outcomes. The current study fills an important void in the literature by identifying critical combinations of FO timing and quantity associated with adverse outcomes (FO ≥ 5%Day1, FO ≥10%Day1, FO ≥ 5%Day2, and FO ≥ 10%Day2). Those novel findings will help guide the development of interventional strategies and trials targeting the treatment and prevention of clinically relevant FO.
With the recognition that fluid overload (FO) has a detrimental impact on critically ill children, the critical care nephrology community has focused on identifying clinically meaningful targets for intervention. The current study aims to evaluate the epidemiology and outcomes associated with FO in an international multicenter cohort of critically ill children. The current study also aims to evaluate the association of FO at predetermined clinically relevant thresholds and time points (FO ≥ 5% and FO ≥ 10% at the end of ICU days 1 and 2) with outcomes.OBJECTIVESWith the recognition that fluid overload (FO) has a detrimental impact on critically ill children, the critical care nephrology community has focused on identifying clinically meaningful targets for intervention. The current study aims to evaluate the epidemiology and outcomes associated with FO in an international multicenter cohort of critically ill children. The current study also aims to evaluate the association of FO at predetermined clinically relevant thresholds and time points (FO ≥ 5% and FO ≥ 10% at the end of ICU days 1 and 2) with outcomes.Prospective cohort study.DESIGNProspective cohort study.Multicenter, international collaborative of 32 pediatric ICUs.SETTINGMulticenter, international collaborative of 32 pediatric ICUs.A total of 5,079 children and young adults admitted consecutively to pediatric ICUs as part of the Assessment of the Worldwide Acute Kidney Injury, Renal Angina and Epidemiology Study.PATIENTSA total of 5,079 children and young adults admitted consecutively to pediatric ICUs as part of the Assessment of the Worldwide Acute Kidney Injury, Renal Angina and Epidemiology Study.None.INTERVENTIONSNone.The FO thresholds at the time points of interest occurred commonly in the cohort (FO ≥ 5%Day1 in 38.1% [ n = 1753], FO ≥ 10%Day1 in 11.7% [ n = 537], FO ≥ 5%Day2 in 53.3% [ n = 1,539], FO ≥ 10%Day2 in 25.1% [ n = 724]). On Day1, multivariable modeling demonstrated that FO ≥ 5% was associated with fewer ICU-free days, and FO ≥ 10% was associated with higher mortality and fewer ICU and ventilator-free days. On multivariable modeling, FO-peak, Day2 FO ≥ 5%, and Day2 FO ≥ 10% were associated with higher mortality and fewer ICU and ventilator-free days.MEASUREMENTS AND MAIN RESULTSThe FO thresholds at the time points of interest occurred commonly in the cohort (FO ≥ 5%Day1 in 38.1% [ n = 1753], FO ≥ 10%Day1 in 11.7% [ n = 537], FO ≥ 5%Day2 in 53.3% [ n = 1,539], FO ≥ 10%Day2 in 25.1% [ n = 724]). On Day1, multivariable modeling demonstrated that FO ≥ 5% was associated with fewer ICU-free days, and FO ≥ 10% was associated with higher mortality and fewer ICU and ventilator-free days. On multivariable modeling, FO-peak, Day2 FO ≥ 5%, and Day2 FO ≥ 10% were associated with higher mortality and fewer ICU and ventilator-free days.This study found that mild-to-moderate FO as early as at the end of ICU Day1 is associated with adverse outcomes. The current study fills an important void in the literature by identifying critical combinations of FO timing and quantity associated with adverse outcomes (FO ≥ 5%Day1, FO ≥10%Day1, FO ≥ 5%Day2, and FO ≥ 10%Day2). Those novel findings will help guide the development of interventional strategies and trials targeting the treatment and prevention of clinically relevant FO.CONCLUSIONSThis study found that mild-to-moderate FO as early as at the end of ICU Day1 is associated with adverse outcomes. The current study fills an important void in the literature by identifying critical combinations of FO timing and quantity associated with adverse outcomes (FO ≥ 5%Day1, FO ≥10%Day1, FO ≥ 5%Day2, and FO ≥ 10%Day2). Those novel findings will help guide the development of interventional strategies and trials targeting the treatment and prevention of clinically relevant FO.
Author Askenazi, David J
Basu, Rajit K
Gist, Katja M
Goldstein, Stuart L
Akcan-Arikan, Ayse
Selewski, David T
Gorga, Stephen M
Mammen, Cherry
Zappitelli, Michael
Ricci, Zaccaria
Woroniecki, Robert
Soranno, Danielle E
Gillespie, Scott E
Sutherland, Scott M
Author_xml – sequence: 1
  givenname: David T
  surname: Selewski
  fullname: Selewski, David T
  organization: Division of Nephrology, Department of Pediatrics, Medical University of South Carolina, Charleston, SC
– sequence: 2
  givenname: Katja M
  surname: Gist
  fullname: Gist, Katja M
  organization: Division of Cardiology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH
– sequence: 3
  givenname: Rajit K
  surname: Basu
  fullname: Basu, Rajit K
  organization: Ann & Robert Lurie Children's Hospital of Chicago/Northwestern University School of Medicine, Chicago, IL
– sequence: 4
  givenname: Stuart L
  surname: Goldstein
  fullname: Goldstein, Stuart L
  organization: Center for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
– sequence: 5
  givenname: Michael
  surname: Zappitelli
  fullname: Zappitelli, Michael
  organization: Division of Nephrology, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
– sequence: 6
  givenname: Danielle E
  surname: Soranno
  fullname: Soranno, Danielle E
  organization: Section of Pediatric Nephrology, Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN
– sequence: 7
  givenname: Cherry
  surname: Mammen
  fullname: Mammen, Cherry
  organization: Department of Pediatrics, Division of Nephrology, BC Children's Hospital, Vancouver, BC, Canada
– sequence: 8
  givenname: Scott M
  surname: Sutherland
  fullname: Sutherland, Scott M
  organization: Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA
– sequence: 9
  givenname: David J
  surname: Askenazi
  fullname: Askenazi, David J
  organization: Department of Pediatrics, Division of Nephrology, Pediatric and Infant Center for Acute Nephrology (PICAN), University of Alabama at Birmingham, Birmingham, AL
– sequence: 10
  givenname: Zaccaria
  surname: Ricci
  fullname: Ricci, Zaccaria
  organization: Department of Health Science, University of Florence, Firenze, Italy
– sequence: 11
  givenname: Ayse
  surname: Akcan-Arikan
  fullname: Akcan-Arikan, Ayse
  organization: Division of Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX
– sequence: 12
  givenname: Stephen M
  surname: Gorga
  fullname: Gorga, Stephen M
  organization: Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI
– sequence: 13
  givenname: Scott E
  surname: Gillespie
  fullname: Gillespie, Scott E
  organization: Division of Critical Care Medicine, Department of Pediatrics, Emory University, Atlanta, GA
– sequence: 14
  givenname: Robert
  surname: Woroniecki
  fullname: Woroniecki, Robert
  organization: Division of Nephrology, Department of Pediatrics, Renaissance School of Medicine at Stonybrook Children's Hospital, Stony Brook, NY
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36821787$$D View this record in MEDLINE/PubMed
BookMark eNpNUW1r3DAMNqNjfdn-wRj62EGvc5zk7OxbCHfbsZaD7qAfDydWri6OndnORv7ufsl8bQfVB0lIj55HQufkxDqLhHzM6HVGK_6laW6v6SsreZW9IWdZmdMFZVV-8io_JechPFKaFSXP35HTfClYxgU_I383wyi7CK6H-IBwKw9Wx0khSKtgpwdtD8fe2kxawfY3euOkAmdhO8XODRhAW2i8jrqTxsywMQaaB22UR_sVarjD0fkIa--GZ4HJJCjaiB42R29l1M5KA3UIGMKQWkfBe-eN-qPTInU3RYQfWllM9PZx8vNVon0asQdt5dXTrqsxgQftjDvMcFnf13erz_AznTK_J297aQJ-eIkXZLde7Zrvi5vtt01T3yy6vGTLRYFVznpeCC6yvmItU1lL-76thBB5VbG-bCmWBW_zLFWFYDntlq0sulJyji27IJfPtKN3vyYMcT_o0KEx0qKbwp5xQekyKZUJ-ukFOrUDqv3o9SD9vP__FvYPnIaUEg
CitedBy_id crossref_primary_10_1186_s13054_023_04746_6
crossref_primary_10_1007_s12098_024_05059_4
crossref_primary_10_1097_SHK_0000000000002483
crossref_primary_10_1097_CCM_0000000000005927
crossref_primary_10_1007_s00431_024_05628_x
crossref_primary_10_1016_j_chstcc_2023_100043
crossref_primary_10_1016_j_sempedsurg_2023_151332
crossref_primary_10_1007_s44253_023_00014_1
crossref_primary_10_1007_s44253_024_00038_1
crossref_primary_10_1053_j_ajkd_2023_12_017
crossref_primary_10_1186_s12882_025_04033_2
crossref_primary_10_5005_jp_journals_10071_24972
crossref_primary_10_1097_CCE_0000000000001291
crossref_primary_10_1038_s41390_025_04218_3
crossref_primary_10_1097_PCC_0000000000003373
crossref_primary_10_1097_PCC_0000000000003693
crossref_primary_10_1038_s41598_024_73588_1
crossref_primary_10_1097_MOP_0000000000001347
crossref_primary_10_1007_s40262_025_01485_5
crossref_primary_10_1136_bmjpo_2023_002094
crossref_primary_10_1007_s00467_023_06235_y
crossref_primary_10_1097_CCE_0000000000001027
crossref_primary_10_1186_s12871_025_03010_4
crossref_primary_10_1097_JTCCM_D_23_00009
crossref_primary_10_1097_CCM_0000000000005880
crossref_primary_10_1001_jamanetworkopen_2023_49871
crossref_primary_10_1177_08850666251359543
crossref_primary_10_1007_s00467_025_06931_x
crossref_primary_10_3389_fped_2024_1484893
crossref_primary_10_1007_s12098_025_05554_2
crossref_primary_10_1093_jac_dkae274
ContentType Journal Article
Copyright Copyright © 2023 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Copyright_xml – notice: Copyright © 2023 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
CorporateAuthor Assessment of the Worldwide Acute Kidney Injury, Renal Angina and Epidemiology (AWARE) Investigators
CorporateAuthor_xml – name: Assessment of the Worldwide Acute Kidney Injury, Renal Angina and Epidemiology (AWARE) Investigators
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1097/CCM.0000000000005791
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1530-0293
ExternalDocumentID 36821787
Genre Multicenter Study
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: P50 DK096418
GroupedDBID ---
.-D
.XZ
.Z2
01R
0R~
1J1
354
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
6J9
6PF
71W
77Y
7O~
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AASXQ
AAUEB
AAWTL
AAXQO
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABPPZ
ABVCZ
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFO
ACGFS
ACIJW
ACILI
ACLDA
ACOAL
ACWDW
ACWRI
ACXJB
ACXNZ
ADGGA
ADHPY
AE6
AEBDS
AENEX
AFDTB
AFEXH
AFSOK
AFUWQ
AGINI
AHOMT
AHQNM
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BOYCO
BQLVK
BYPQX
C45
CGR
CS3
CUY
CVF
DIWNM
DU5
E.X
EBS
ECM
EEVPB
EIF
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
GNXGY
GQDEL
H0~
HLJTE
HZ~
IE0
IKREB
IKYAY
IN~
IPNFZ
JF9
JG8
JK3
JK8
K-A
K-F
K8S
KD2
KMI
L-C
L7B
N9A
NPM
N~7
N~B
O9-
OAG
OAH
OB4
OBH
ODA
ODMTH
ODZKP
OHH
OHYEH
OJAPA
OL1
OLB
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
PONUX
RIG
RLZ
S4R
S4S
TEORI
TSPGW
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
XXN
XYM
YCJ
YFH
YOC
YOJ
ZFV
ZY1
~9M
7X8
ABPXF
ABXYN
ABZZY
ACDOF
ACZKN
ADKSD
ADSXY
AE3
AFBFQ
AFMBP
AFNMH
AHQVU
AOQMC
ID FETCH-LOGICAL-c3526-4e932f748781f92b2d1b0ffb98883992f5b0e547b31ffb88230c6ba4c5a77eb2
IEDL.DBID 7X8
ISICitedReferencesCount 30
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00003246-202305000-00006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1530-0293
IngestDate Thu Oct 02 10:38:51 EDT 2025
Wed Feb 19 02:05:32 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License Copyright © 2023 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3526-4e932f748781f92b2d1b0ffb98883992f5b0e547b31ffb88230c6ba4c5a77eb2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 36821787
PQID 2780065265
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2780065265
pubmed_primary_36821787
PublicationCentury 2000
PublicationDate 2023-05-01
20230501
PublicationDateYYYYMMDD 2023-05-01
PublicationDate_xml – month: 05
  year: 2023
  text: 2023-05-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Critical care medicine
PublicationTitleAlternate Crit Care Med
PublicationYear 2023
References 37439648 - Crit Care Med. 2023 Aug 1;51(8):e169-e170
References_xml – reference: 37439648 - Crit Care Med. 2023 Aug 1;51(8):e169-e170
SSID ssj0014573
Score 2.5572207
Snippet With the recognition that fluid overload (FO) has a detrimental impact on critically ill children, the critical care nephrology community has focused on...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 606
SubjectTerms Acute Kidney Injury - epidemiology
Acute Kidney Injury - therapy
Child
Critical Illness - epidemiology
Critical Illness - therapy
Heart Failure
Humans
Intensive Care Units, Pediatric
Prospective Studies
Water-Electrolyte Imbalance
Young Adult
Title Impact of the Magnitude and Timing of Fluid Overload on Outcomes in Critically Ill Children: A Report From the Multicenter International Assessment of Worldwide Acute Kidney Injury, Renal Angina, and Epidemiology (AWARE) Study
URI https://www.ncbi.nlm.nih.gov/pubmed/36821787
https://www.proquest.com/docview/2780065265
Volume 51
WOSCitedRecordID wos00003246-202305000-00006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bixMxFA7qiuyL913XG0fwQWGHnXsSX2QoLS7a7iIF-1ZylZExs7YdpX_XX-JJZmrxQRCch3mYIcmBnCRfck6-j5CXnJUyzSyPDE2llzDjESu4iYRNylRkgpUq8Mx-oLMZWyz45XDgth7SKndzYpiodav8GflZSplfLtOyeHv1LfKqUT66OkhoXCcHGUIZ79V0sY8i5EWIMOOgjqMY17Xd1TlOz0ajaU9dODxFYOn8G8gMi83kzv-aeZfcHmAmVL1f3CPXjLtPbk2HQPoD8vM83I6E1gIiQJgKn0TUaQPCaZh7pa_P_t-k6WoNF-juTSs0tA4uug0aYtZQO9jJJDRbOG8aGA33wt9ABT2uh8mq_do3EFg-PP_nCv44hITqNzWobzDk9vyo0ZBKdRsD72vtDFbvvmDfn2K1oYjnUBSnwdbxXuF2C6-qT9XH8WvwyZHbh2Q-Gc9H76JB7iFSnqQ_yg1iSUtxB8USy1OZ6kTG1kqOm3RPn2sLGZsipzJL8CvzEUJVSpGrQlBqZHpEbrjWmUcECikSlWhGBRe55UyaWGSpzhTiFcUKfUJe7DpviaPJh0iEM223Xu6774Qc9x6wvOppP5ZZyXD_xujjfyj9hBx6Xfo-M_IpObA4l5hn5Kb6vqnXq-fBTfE9u5z-Amup80E
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+the+Magnitude+and+Timing+of+Fluid+Overload+on+Outcomes+in+Critically+Ill+Children%3A+A+Report+From+the+Multicenter+International+Assessment+of+Worldwide+Acute+Kidney+Injury%2C+Renal+Angina%2C+and+Epidemiology+%28AWARE%29+Study&rft.jtitle=Critical+care+medicine&rft.au=Selewski%2C+David+T&rft.au=Gist%2C+Katja+M&rft.au=Basu%2C+Rajit+K&rft.au=Goldstein%2C+Stuart+L&rft.date=2023-05-01&rft.eissn=1530-0293&rft.volume=51&rft.issue=5&rft.spage=606&rft_id=info:doi/10.1097%2FCCM.0000000000005791&rft_id=info%3Apmid%2F36821787&rft_id=info%3Apmid%2F36821787&rft.externalDocID=36821787
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1530-0293&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1530-0293&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1530-0293&client=summon